Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Newcastle Disease Virus (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - Human / Clinical Studies

Table 3. Studies of NDV-Infected Tumor Cell Vaccines in Which Therapeutic Benefit Was Assesseda

Reference Citation(s) Type of Study Type of Cancer No. of Patients: Enrolled; Treated; Controlb Strongest Benefit Reportedc Concurrent Therapyd Level of Evidence Scoree
No. = number; wk = week.
a Refer to text and theNCI Dictionary of Cancer Termsfor additional information and definition of terms.
b Number of patients treated plus number of patients control may not equal number of patients enrolled; number of patients enrolled = number of patients initially recruited/considered by the researchers who conducted a study; number of patients treated = number of enrolled patients who were given the treatment being studiedAND for whom results were reported; historical control subjects are not included in number of patients enrolled.
c The strongest evidence reported that the treatment under study has anticancer activity or otherwise improves the well-being of cancer patients.
d Chemotherapy, radiation therapy, hormonal therapy, or cytokine therapy given/allowed at the same time as vaccine therapy.
e For information about levels of evidence analysis and an explanation of the level of evidence scores, refer toLevels of Evidence for Human Studies of Cancer Complementary and Alternative Medicine.
f Only 48 patients were treated with NDV-infected tumor cell vaccines; the remaining patients were treated with another type of vaccine.
g The patients were divided into groups that received a high-quality vaccine or a low-quality vaccine; the low-quality vaccine groups served as the controls; 32, 13, and 18 patients with early breast cancer, metastatic breast cancer, and metastatic ovarian cancer, respectively, received high-quality vaccines; the corresponding low-quality vaccine groups contained 31,14, and 13 patients.
h There were 39 evaluable patients in this study, but findings were reported for only 24 patients.
i Article does not provide enough information.
[32] Phase II/III (adjuvant setting) Melanoma 29; 21; 8 No advantage of vaccine for disease free survival or overall survival None 1iA
[29] Phase III (adjuvant setting) Colorectal with liver metastases 51; 25; 26 Planned subgroup analysis, overall and disease free survival advantages in the colon of cancer patients Protocol therapy was given after complete surgical resection of primary tumor and liver metastases 1iiA
[31] Phase II Glioblastoma 35; 23; 87 (concurrent controls identified from within same hospital) Median progression-free survival of vaccinated patients was 40 wk (vs. 26 wk in controls; log-rank test,P = .024), median OS of vaccinated patients was 100 wk (vs. 49 wk in controls; log-rank test,P< .001) Protocol therapy after surgical debulking of tumor followed by radiation therapy 2A
[15,22] Phase II trial Metastatic colorectal 23; 23; Historical controls Improved disease-free survival No 3iiA
[23] Phase II trial Ovarian 82; 24h; None Improved disease-free survival Yes 3iiDi
[16] Phase II trial Advanced colorectal 57; 48f; Historical controls Improved overall survival No 3iiiA
[17] Retrospective analysis Early breast 63; 63; Internal controlsg Improved overall survival Yes 3iiiA
[21] Phase II trial Metastatic renal cell 40; 40; Historical controls Improved overall survival, 11 patients with complete/partial responses Yes 3iiiA
[19] Phase II trial Various advanced 43; 31; None Complete tumor response, 1 patient Yes 3iiiDiii
[33] Phase II Gastrointestinal tumors, stage IV 25; 25; 0 1 Complete response, 5 partial responses, overall response rate = 24% None described 3iiiDiii
[33] Phase III Colorectal 567; 310; 257 Higher mean and median survival for vaccination group compared to the resection group alone None described None describedi
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16
Next Article:

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas